TrialRMD open2022

Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.

Kevin Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.